American Society of Hematology

Fig. 1.

Fig. 1. DFS for patients with the +8 cytogenetic abnormality. Those coharboring the t(9;22) have a similar outcome to those without the t(9;22) (P = .87).

DFS for patients with the +8 cytogenetic abnormality. Those coharboring the t(9;22) have a similar outcome to those without the t(9;22) (P = .87).

This Feature Is Available To Subscribers Only

Sign In or Create an Account